CLASS II Device recall · Reported 20 Sep 2017 · FDA Enforcement Report

Sekisui Diagnostics Sekure Chemistry Acetaminophen L3K recalled

Beckman Coulter is recalling Sekisui Diagnostics Sekure Chemistry Acetaminophen L3K, distributed nationwide in the US. The recall was initiated on 20 Jul 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll lots
Quantity recalled320 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3118-2017
FDA event ID
77896
Recalling firm
Beckman Coulter, Brea, CA
Classification
Class II
Status
Terminated
Recall initiated
20 Jul 2017
FDA classified
12 Sep 2017
Reported
20 Sep 2017
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Other Reasons

Timeline

20 Jul 2017Recall initiated by company
12 Sep 2017Classified by FDA+54 days
20 Sep 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Reagent carryover from Sekisui ACTH when utilized on the BEC AU 680 analyzer may lead to falsely elevated BEC Lipase recovery exceeding the total precision specification.

Product as listed by the FDA

Sekisui Diagnostics Sekure Chemistry Acetaminophen L3K , Ref. 506-30. The firm names on the label are Sekisui Diagnostics (UK) Limited, United Kingdom, and Sekisui Diagnostics P.E.I. Inc., Canada. Used in laboratory testing.

Where it was distributed

Distribution US nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Reagent carryover from Sekisui ACTH when utilized on the BEC AU 680 analyzer may lead to falsely elevated BEC Lipase recovery exceeding the total precision specification.

Which lots are affected?

All lots

Where was it sold?

Distribution US nationwide.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Beckman Coulter

All 334

Other Test Kits & Diagnostics recalls

All 2,656